Kidney Week 2013: New clinical trials reveal insights on treating patients with kidney disease

09-11-2013 EurekAlert!Comments (0)

AbataceptPharmaceutical

An investigational drug called ZS-9 demonstrated promising Phase 2 clinical trial results for treating abnormally high potassium levels in patients with chronic kidney disease.The immune drug abatacept did not provide benefits above standard treatment for patients with kidney inflammation caused by lupus.

Read more on EurekAlert!

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top